Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins] - PubMed (original) (raw)

Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]

A Sniderman et al. Proc Natl Acad Sci U S A. 1980 Jan.

Abstract

Most patients with coronary artery disease do not have elevated plasma or low density lipoprotein (LDL) cholesterol. To test whether the protein moiety of LDL, LDL B, might be a parameter to identify ischemic heart disease, the plasma cholesterol, triglyceride, LDL cholesterol, and LDL B were measured in 100 consecutive patients undergoing cardiac catheterization. On the basis of coronary angiography, these patients were divided into two groups: group I, 31 patients without, and group II, 59 patients with significant coronary artery disease. Although cholesterol, triglyceride, and LDL cholesterol levels were all significantly higher in group II, discriminant analysis indicated that LDL B concentrations most clearly separated the two groups. In group I (noncoronary), LDL B was 82 +/- 22 mg/100 ml, whereas in group II, LDL B was 118 +/- 22 mg/100 ml. The B protein level in group I was similar to other normal groups studied (35 asymptomatic male physicians, 83 +/- 11 mg/100 ml; 90 normolipidemic medical students, 72 +/- 17 mg/100 ml). The results therefore indicate that not only does LDL B better separate coronary and noncoronary groups than other lipid parameters studied, but also, among those with coronary artery disease, there exists a group with normal LDL cholesterol but with levels of LDL B protein similar to those observed in type II hyperlipoproteinemia. The explanation for the altered LDL composition observed in this group remains to be elucidated.

PubMed Disclaimer

Cited by

Apolipoprotein B: Bridging the Gap Between Evidence and Clinical Practice.
De Oliveira-Gomes D, Joshi PH, Peterson ED, Rohatgi A, Khera A, Navar AM. De Oliveira-Gomes D, et al. Circulation. 2024 Jul 2;150(1):62-79. doi: 10.1161/CIRCULATIONAHA.124.068885. Epub 2024 Jul 1. Circulation. 2024. PMID: 38950110 Review.
Determination of serum apolipoprotein B by competitive enzyme-linked immunoassay.
Reisinger H, Strobl W, Hubrich B, Widhalm K. Reisinger H, et al. J Inherit Metab Dis. 1991;14(2):247-52. doi: 10.1007/BF01800598. J Inherit Metab Dis. 1991. PMID: 1909404
Studies on the production of low density lipoproteins by perfused livers from nonhuman primates. Effect of dietary cholesterol.
Johnson FL, St Clair RW, Rudel LL. Johnson FL, et al. J Clin Invest. 1983 Jul;72(1):221-36. doi: 10.1172/jci110961. J Clin Invest. 1983. PMID: 6874948 Free PMC article.

References

1. Science. 1970 Jul 31;169(3944):493-5 - PubMed
1. J Atheroscler Res. 1963 Jul-Aug;3:334-6 - PubMed
1. J Biol Chem. 1971 Sep 10;246(17):5454-65 - PubMed
1. Lancet. 1972 Apr 22;1(7756):865-8 - PubMed
1. Clin Chem. 1972 Jun;18(6):499-502 - PubMed

Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins] - PubMed (original) (raw)